Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin
Pain, Postoperative
About this trial
This is an interventional treatment trial for Pain, Postoperative focused on measuring gabapentin, Analgesic Drugs, Analgesics, Nonopioid
Eligibility Criteria
Inclusion Criteria:
- Patients of age 10-19 with an American Society of Anesthesiologists patient classification of I to III undergoing surgery to correct idiopathic or neurogenic scoliosis.
Exclusion Criteria:
- Patients who require a surgical approach or technique differing from posterior spinal fusion and/or have allergies to any of the standardized or experimental study medications: acetaminophen, gabapentin, hydromorphone, ketorolac or oxycodone.
Sites / Locations
- Oregon Health and Science University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Gabapentin
Simple Syrup
Gabapentin 15 milligrams per kilogram will be given orally one time pre-operatively. Gabapentin will be continued at a dose of 10 milligrams per kilogram every eight hours orally starting as soon as the patient is admitted to his or her floor bed in the hospital.
Simple syrup compounded by the Oregon Health and Science University research pharmacy will be administered in the same volume as if the patient were receiving the Gabapentin both pre-operatively and every eight hours after the patient is admitted to his or her floor bed in the hospital.